Jiangsu Aoyang Health Industry Co., Ltd. (002172) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Jiangsu Aoyang Health Industry Co., Ltd.

Why is Jiangsu Aoyang Health Industry Co., Ltd. ?

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 5.48%

Poor long term growth as Net Sales has grown by an annual rate of -12.46% and Operating profit at 17.16% over the last 5 years
The company is Net-Debt Free

Negative results in Mar 26

INTEREST COVERAGE RATIO(Q) Lowest at 196.69
ROCE(HY) Lowest at 16.77%
INTEREST(Q) At CNY 8.29 MM has Grown at 33.05%

With ROE of 17.10%, it has a very expensive valuation with a 12.19 Price to Book Value

Over the past year, while the stock has generated a return of -18.64%, its profits have risen by 6.9% ; the PEG ratio of the company is 10.3

Below par performance in long term as well as near term

Along with generating -18.64% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Garments & Apparels)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Jiangsu Aoyang Health Industry Co., Ltd. for you?

Medium Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Jiangsu Aoyang Health Industry Co., Ltd.

-22.86%

0.54

32.24%

China Shanghai Composite

21.43%

1.55

13.83%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-12.46%

EBIT Growth (5y)

17.16%

EBIT to Interest (avg)

-1.32

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

4.28

Sales to Capital Employed (avg)

1.56

Tax Ratio

41.88%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

5.48%

ROE (avg)

10.97%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

12.19

EV to EBIT

40.75

EV to EBITDA

24.18

EV to Capital Employed

3.52

EV to Sales

1.61

PEG Ratio

10.27

Dividend Yield

ROCE (Latest)

8.63%

ROE (Latest)

17.10%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 224.4 MM

-26What is not working for the Company

INTEREST COVERAGE RATIO(Q)

Lowest at 196.69

ROCE(HY)

Lowest at 16.77%

INTEREST(Q)

At CNY 8.29 MM has Grown at 33.05%

PRE-TAX PROFIT(Q)

At CNY 7.97 MM has Fallen at -49.61%

NET PROFIT(Q)

At CNY 5.24 MM has Fallen at -52.44%

RAW MATERIAL COST(Y)

Grown by 11.5% (YoY

CASH AND EQV(HY)

Lowest at CNY 720.24 MM

NET SALES(Q)

Lowest at CNY 406.69 MM

OPERATING PROFIT(Q)

Lowest at CNY 16.31 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 4.01 %

Here's what is working for Jiangsu Aoyang Health Industry Co., Ltd.

Operating Cash Flow

Highest at CNY 224.4 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Here's what is not working for Jiangsu Aoyang Health Industry Co., Ltd.

Interest Coverage Ratio

Lowest at 196.69 and Fallen

In each period in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Interest

At CNY 8.29 MM has Grown at 33.05%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Pre-Tax Profit

At CNY 7.97 MM has Fallen at -49.61%

over average net sales of the previous four periods of CNY 15.82 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 5.24 MM has Fallen at -52.44%

over average net sales of the previous four periods of CNY 11.01 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Net Sales

Lowest at CNY 406.69 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Net Sales

At CNY 406.69 MM has Fallen at -9.81%

over average net sales of the previous four periods of CNY 450.95 MM

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY 16.31 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 4.01 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Cash and Eqv

Lowest at CNY 720.24 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Raw Material Cost

Grown by 11.5% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales